Biopharmaceutical formulation

被引：19
|
作者：
Lee, JC [1 ]
机构：
[1] Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA
来源：
CURRENT OPINION IN BIOTECHNOLOGY | 2000年 / 11卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S0958-1669(99)00058-0
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The rapid maturation of the field of biopharmaceutical formulation is the result of the simultaneous development of a thermodynamic mechanism for protein-solvent interaction and identification of natural chemicals employed by nature to stabilize proteins in response to environmental stresses. In general, these cosolvents are excluded from the protein surface. Proteins are maintained in their native folded conformations by these cosolvents as a result of the highly unfavorable interaction between cosolvents and peptide backbones, which would be exposed to the cosolvent upon unfolding.
引用
收藏
页码：81 / 84
页数：4
相关论文
共 50 条
  • [11] Formulation and biopharmaceutical evaluation of a transdermal patch containing aceclofenac
    Yun-Seok Rhee
    Thuong Nguyen
    Eun-Seok Park
    Sang-Cheol Chi
    Archives of Pharmacal Research, 2013, 36 : 602 - 607
  • [12] Formulation development for cancer compounds - Biopharmaceutical issues and perspectives
    Srinivas, Nuggehally R.
    ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (02) : 90 - 93
  • [13] Formulation and biopharmaceutical evaluation of osmotic matrix tablets of diclofenac sodium
    Rani, M
    Surana, R
    Sankar, C
    Mishra, B
    DRUG DELIVERY, 2004, 11 (04) : 263 - 270
  • [14] Conformational and Colloidal Stability Studies to Predict the Best Biopharmaceutical Formulation
    Cristovao, Joana S.
    Neto, Salome
    BIOPHARM INTERNATIONAL, 2021, 34 (09) : 34 - 40
  • [15] FORMULATION OF DIAZEPAM CONTAINING RECTAL SUPPOSITORIES AND EXPERIENCES OF THEIR BIOPHARMACEUTICAL STUDY
    REGDON, G
    BACSKAY, I
    KATA, M
    SELMECZI, B
    SZIKSZAY, M
    SANTA, A
    BALINT, GS
    PHARMAZIE, 1994, 49 (05): : 346 - 349
  • [16] Formulation of Propolis Phenolic Acids Containing Microemulsions and Their Biopharmaceutical Characterization
    Zilius, Modestas
    Ramanauskiene, Kristina
    Juskaite, Vaida
    Briedis, Vitalis
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [17] Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins
    Onoue, Satomi
    Suzuki, Hiroki
    Seto, Yoshiki
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (27) : 3867 - 3874
  • [18] QbD Enabled Formulation Development of Nanoemulsion of Nimodipine for Improved Biopharmaceutical Performance
    Patra, Ch. Niranjan
    Mishra, Archana
    Jena, Goutam Kumar
    Panigrahi, Kahnu Charan
    Sruti, Jammula
    Ghose, Debashish
    Sahoo, Laxmidhar
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2023, 18 (03) : 1279 - 1297
  • [19] Development of a rapid and low-cost tool for biopharmaceutical formulation screening
    Quigley, Amanda
    Hassard, Stuart
    Bracewell, Dan
    NEW BIOTECHNOLOGY, 2014, 31 : S128 - S128
  • [20] Biopharmaceutical study of nanostructured formulation of the anticancer drug derivative of nitrosoalkylurea lysomustine
    Lantsova, A.
    Kotova, E.
    Sanarova, K.
    Oborotova, N.
    Poloskova, A.
    Barushnikov, A.
    Orlova, O.
    Krasnov, V.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (06) : 469 - 472
12345